1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. VIATRIS INC
Viatris Inc XNAS: VTRS

Viatris Inc Live Share Price Today, Share Analysis and Chart

Await Turnaround
about

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining f...

Read More
9.12 -0.13 (-1.41%)
32.69% Fall from 52W High
7.1M
XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Mid Valuation
43.7 / 100
Momentum Score
Technically Neutral
49.6 / 100
Await Turnaround These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks. View Similar Embed DVM
Analyst Price Target
11
1Yr Price target upside is 25%
8 analysts

8

S

14

W

2

O

2

T

SWOT Analysis

Viatris Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..